Inverse dA (Bz) CNA CPG
CPG for the incorporation of an (otherwise unmodified) reverse (5' to 3') dA nucleobase at the 3' end of an oligonucleotide.
CPG for the incorporation of an (otherwise unmodified) reverse (5' to 3') dA nucleobase at the 3' end of an oligonucleotide.
Phosphoramidite for the incorporation of an internal amino function into an oligonucleotide.
Phosphoramidite for the incorporation of an (otherwise unmodified) reverse (5’ to 3’) dA nucleobase within an oligonucleotide.
CPG column for the incorporation of an (otherwise unmodified) reverse (5' to 3') dA nucleobase at the 3' end of an oligonucleotide.
CPG column for the incorporation of an (otherwise unmodified) reverse (5' to 3') dA nucleobase at the 3' end of an oligonucleotide.
Phosphoramidite used to incorporate a N-methyl-modified deoxyadenosine into an oligonucleotide.
Phosphoramidite used to incorporate a dA nucleobase when creating phosphorodithioate (PS2) linkages.
Phosphoramidite used to incorporate a deoxyadenosine into an oligonucleotide, with an ethylated backbone.
Phosphoramidite used to incorporate a bromo-modified deoxyadenosine internally or at the 5' end of an oligonucleotide.
Monomer for H-phosphonate nucleic acid synthesis.
Europe, Middle East, and Africa | |
---|---|
UK | +44 1992 470 757 |
Germany | +49 30 5304 2200 |
North America, Latin America | |
Wisconsin, USA | +1 888 575 9695 |
Asia Pacific | |
China | +8621-22509000 |
Singapore | +65 6734 4800 |